8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors1,292 citations

Influence of electromagnetic Fields on reproductive system of male rats

Bioeffects Seen

Kumar S, Behari J, Sisodia R · 2013

Share:

10 GHz microwave radiation exposure was associated with significant reproductive system damage in male rats, including reduced fertility potential markers.

Plain English Summary

Summary written for general audiences

This study examined the effects of 10 GHz microwave radiation exposure on the reproductive system of male Wistar rats over 45 days. The researchers found multiple indicators of reproductive damage in exposed animals, including seminiferous tubule shrinkage, DNA strand breaks, decreased testosterone levels, and chromosomal aberrations.

Why This Matters

The study employed multiple complementary analytical methods (electron microscopy, comet assay, flow cytometry, testosterone assays) to assess reproductive effects at different biological levels. However, the discrepancy between the title indicating a human study and the abstract describing rat experiments represents a data entry error in the study record.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Kumar S, Behari J, Sisodia R (2013). Influence of electromagnetic Fields on reproductive system of male rats.
Show BibTeX
@article{kumar_s_behari_j_sisodia_r_ce3755,
  author = {Kumar S and Behari J and Sisodia R},
  title = {Influence of electromagnetic Fields on reproductive system of male rats},
  year = {2013},
  doi = {10.1038/leu.2013.313},
  
}
DOI: 10.1038/leu.2013.313PubMed: 23078358

Quick Questions About This Study

Median survival increased from 4.6 years for patients diagnosed in 2001-2005 to 6.1 years for those diagnosed in 2006-2010, representing a 33% improvement in survival time.
Patients over 65 experienced the most dramatic improvement, with 6-year survival rates jumping from 31% to 56% between the two time periods studied.
Yes, first-year mortality dropped significantly from 16% in 2001-2005 to just 10% in 2006-2010, indicating better early treatment outcomes and reduced immediate complications.
The improvements were directly linked to using one or more new therapeutic agents in initial treatment, representing a major advancement in multiple myeloma care protocols.
Of the 1,038 patients studied over nearly 6 years of follow-up, 47% remained alive at the last follow-up, demonstrating the serious nature of this blood cancer.